INTS vs NTAP
Intensity Therapeutics, Inc. Common stock (INTS) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported NTAP revenue for 2025-04-25 was $6.57B. Net income was $1.19B. Revenue was up 4.9% from 2024-04-26 to 2025-04-25. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
INTS currently screens at market cap $7.7M. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the INTS and NTAP stock pages for the full models.
Not investment advice.